Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
205 Leser
Artikel bewerten:
(1)

ClariMed Inc.: ClariMed Appoints Ross Dehmoobed as Vice President of Software and Launches Comprehensive Digital Health Services

Finanznachrichten News

CHADDS FORD, Pa., Jan. 7, 2025 /PRNewswire/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, has announced the appointment of Ross Dehmoobed as its Vice President of Software and Digital Services.

Ross Dehmoobed, VP of Software and Digital Services at ClariMed

With nearly two decades of experience in software engineering and leadership across safety-critical and regulated industries, particularly medical devices and automotive, Ross brings a wealth of expertise across the spectrum of medical device software. His extensive background spans in vitro diagnostics (IVD), patient monitoring, cell therapy, digital pathology, and much more, where he has consistently delivered innovative, scalable, secure software solutions that meet rigorous regulatory standards, advance the digitization of healthcare and diagnostics, and exceed client expectations.

In his new role as Vice President of Software and Digital Services at ClariMed, Ross will spearhead the company's efforts to advance its software and digital health capabilities, focusing on building a world-class team, driving innovation, and delivering exceptional value to clients. His leadership will ensure ClariMed continues to develop transformative solutions in areas such as software development, UX/UI design, AI/ML, cloud and connectivity, and cybersecurity. These efforts will support the company's mission to revolutionize healthcare and diagnostics through cutting-edge digital solutions while maintaining a steadfast commitment to client satisfaction.

"Ross's appointment represents a significant milestone in ClariMed's growth trajectory," said Kelley Kendle, CEO of ClariMed. "His deep expertise in regulated industries and proven track record in developing compliant software solutions will be instrumental in expanding our capabilities and delivering enhanced value to our clients."

Before joining ClariMed, Ross held the position of Vice President of Software and Platforms at Veranex (previously Fusion Biotec), where he played a pivotal role in building and scaling a multidisciplinary software team. Under his leadership, the team grew capabilities across embedded systems, mobile, cloud, and web solutions, with a strong focus on software quality and cybersecurity. Ross also drove initiatives that enhanced client value through innovative software strategies and ensured seamless delivery of compliant solutions for regulated industries.

"At ClariMed, I look forward to expanding our software and digital health capabilities and to building a team of trailblazing experts who can redefine the digitization of healthcare and diagnostics. Growing and mentoring high-performing teams has been a hallmark of my career, and I'm excited to replicate that success here. Together, we will push the boundaries of innovation in AI/ML, cloud connectivity, and cybersecurity, delivering transformative solutions that empower healthcare organizations, deliver exceptional value for our clients, and ensure their satisfaction," said Ross Dehmoobed.

Ross's leadership, technical expertise, and strategic vision will further strengthen ClariMed's position as a global industry leader in the human factors and medical device industries.

About ClariMed:

ClariMed is a human-centered development and regulatory practice for medical products developed by Pharmaceutical and Medical device manufacturers. Our best-of-breed professional services cultivate innovation while ensuring the safe and effective use of medical products. Visit us at www.Clarimed.com.

For media inquiries, please contact: press@clarimed.com

ClariMed: Designing the Future of Health

Photo - https://mma.prnewswire.com/media/2591736/ClariMed_Inc_Ross_Dehmoobed.jpg
Logo - https://mma.prnewswire.com/media/1991389/ClariMed___Logo_v2.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/clarimed-appoints-ross-dehmoobed-as-vice-president-of-software-and-launches-comprehensive-digital-health-services-302344483.html

© 2025 PR Newswire
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.